Submucosal tunneling endoscopic septum division for Zenker’s diverticulum in a patient with scoliosis and stent impaction
Endoscopy · 01.12.2025 · 57 (S 01 S 01) · E1395-E1396
DOI: 10.1055/a-2743-9321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.12.2025. Verfasst von Zhi-Yu Xiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Project of Shanghai Municipal Science and Technology Committee.
Abstract (Originalsprache)
A 72-year-old woman was admitted because of dysphagia and recurrent chest pain for the past 6 months. Two years ago, she was diagnosed with Zenker’s diverticulum at a local hospital and underwent esophageal stent placement for occlusion. The patient also presented with severe congenital scoliosis ([ Fig. 1 ] a, b ), with a height of 115 cm and a weight of 35 kg. Despite the initial intervention, her symptoms persisted with worsening dysphagia, chest pain, and multiple episodes of aspiration pneumonia over the past 6 months. Endoscopic evaluation revealed stent migration and impaction, with unsuccessful removal attempts at local hospital ([ Fig. 1 ] c ). The endoscopic stent retrieval combined with submucosal tunneling endoscopic septum division (STESD) was proposed after a multidisciplinary discussion with the anesthesia, orthopedic, and respiratory departments. Fig. 1 Images showing significantly increased challenges and risks. a, b Radiographic images showing severe congenital scoliosis. c The displaced and impacted stent filled with food. The procedure involved five steps ([ Video 1 ]). First, granulation was dissected with a IT knife at the impacted stent site and stent retrieval was successfully achieved ([ Fig. 2 ] a ). Second, a mucosal incision was created 3 cm proximal to the diverticular septum ([ Fig. 2 ] b ). Third, the submucosal longitudinal tunneling was established using a hybrid knife ([ Fig. 2 ] c, d ). As the scoliosis caused esophageal tortuosity, the tunnel was created according to the direction of the esophageal travel. Fourth, complete transection of the diverticular septum was performed ([ Fig. 2 ] e ). Fifth, the mucosal entry was closed with endoclips after hemostasis ([ Fig. 2 ] f ). Download Video Submucosal tunneling endoscopic septum division for Zenker’s diverticulum in a patient with scoliosis and stent impaction.Video 1 Fig. 2 Endoscopic images showing a separation of the granulation tissue around the esophageal stent. b A mucosal incision. c The submucosal longitudinal tunneling. d Tunneling performed at both sides of the septum. e The septum being prepared for complete transection. f The mucosal entry closed with endoclips after hemostasis. The procedure duration was 80 minutes. The patient was discharged on postoperative day 8 after an uneventful recovery. One-month postoperative esophagography demonstrated restored luminal patency without contrast retention ([ Fig. 3 ]). Fig. 3 Esophagography showing restored luminal patency without contrast retention. STESD has become widely accepted as a minimally invasive procedure for treating Zenker’s diverticulum [ 1 ]. We herein report the first case of Zenker’s diverticulum in a patient with severe scoliosis complicated by stent migration and impaction managed by STESD. The procedure demonstrated significantly increased risks. This case highlights the importance of tailored minimally invasive technique selection and multidisciplinary collaboration. Endoscopy_UCTN_Code_TTT_1AO_2AL Endoscopy E-Videos https://eref.thieme.de/e-videos E-Videos is an open access online section of the journal Endoscopy , reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/ ). This section has its own submission website at https://mc.manuscriptcentral.com/e-videos . Publication History Article published online: 08 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Autor:innen und Institutionen
- Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Nursing Department, Zhongshan Hospital, Fudan University, Shanghai, China.
- Shanghai Collaborative Innovation Center of Endoscopy, Shanghai, China.
Förderung
- Major Project of Shanghai Municipal Science and Technology Committee
Zitieren
APA
Xiang, Z. Y., Fan, L., Lin, S. L., Ma, L., & Zhou, P. H. (2025). Submucosal tunneling endoscopic septum division for Zenker’s diverticulum in a patient with scoliosis and stent impaction. Endoscopy, 57(S 01 S 01), E1395-E1396. https://doi.org/10.1055/a-2743-9321
Vancouver
Xiang ZY, Fan L, Lin SL, Ma L, Zhou PH. Submucosal tunneling endoscopic septum division for Zenker’s diverticulum in a patient with scoliosis and stent impaction. Endoscopy. 2025;57(S 01 S 01):E1395-E1396. doi:10.1055/a-2743-9321
BibTeX
@article{Xiang2025,
author = {Xiang, Zhi-Yu and Fan, Lina and Lin, Sheng-Li and Ma, Lili and Zhou, Ping-Hong},
title = {Submucosal tunneling endoscopic septum division for Zenker’s diverticulum in a patient with scoliosis and stent impaction},
journal = {Endoscopy},
year = {2025},
volume = {57},
number = {S 01 S 01},
pages = {E1395--E1396},
doi = {10.1055/a-2743-9321}
}
EUVIMED